History of Bleeding and Safety of Abelacimab vs. Rivaroxaban in Atrial Fibrillation:A Secondary Analysis of AZALEA-TIMI 71 (AHA 2026) - Oct 8, 2026 - Abstract #MDP1489; Pres time: Nov 8, 2026; 12:46 PM - 12:51 PM; Location: Moderated Digital Poster 3‚ Clinical Science Zone 1; In-Person; No abstract available
Clinical • Atrial Fibrillation • Cardiovascular
|
|
Shih-Ann Chen; Robert Giugliano; Shaun Goodman; Erica Goodrich; BOYOUNG JOUNG; Robert Gabor Kiss; David Morrow; Sanobar Parkar; Siddharth Patel; Christian Ruff; Marc Sabatine; Mahmoud Shams; Jeffrey Weitz; Wojtek Wojakowski
|